文献速递运动医学关节外科

个体化前交叉韧带移植物匹配:腘绳肌腱、髌腱与股四头肌腱移植物横截面积与ACL止点面积的体内比较

Individualized Anterior Cruciate Ligament Graft Matching: In Vivo Comparison of Cross-sectional Areas of Hamstring, Patellar, and Quadriceps Tendon Grafts and ACL Insertion Area.
PubMed 文献 · Am J Sports Med · 2018-07-30

该描述性实验室研究回顾性评估46例接受腘绳肌腱(HS)自体移植物ACL重建患者的胫骨止点面积与HS移植物直径,并用MRI测量髌腱(PT)与股四头肌腱(QT)移植物横截面积(CSA)。结果显示三种移植物CSA与ACL止点面积个体差异大且互不相关,PT易偏小、QT易偏大,MRI测量或有助于术前个体化选择移植物。

要点

  • ACL胫骨止点平均面积107.2 mm²(范围60.5-155.5 mm²),PT、HS、QT平均CSA分别为33.2、55.3、71.4 mm²。
  • 按止点面积50.2%±15%为目标,HS组82.7%在范围内,PT组65.2%低于范围,QT组60.9%高于范围。
  • ACL止点大小与三种常用移植物CSA个体差异大且互不相关,仅按移植物大小可能无法充分恢复原生ACL尺寸。

核心结论

  • ACL止点大小与三种常用移植物的CSA在每个患者间差异很大,且彼此不相关。
  • 若仅由获取的自体移植物大小决定重建ACL尺寸,原生ACL大小可能无法被充分恢复;PT移植物倾向于使原生ACL偏小,QT可能使其偏大。

研究设计与样本

  • 描述性实验室研究,回顾性评估46例接受腘绳肌腱(HS)自体移植物ACL重建患者的术中胫骨止点面积与HS移植物直径数据。
  • 对每例患者另行用磁共振成像测量可能的髌腱(PT)与股四头肌腱(QT)自体移植物的横截面积(CSA)。
  • 计算并比较三种可能移植物恢复胫骨止点面积的百分比。

主要发现

  • ACL胫骨止点平均面积为107.2 mm²(范围60.5-155.5 mm²)。
  • PT、HS、QT的平均CSA分别为33.2、55.3、71.4 mm²。
  • 所有移植物评估中,胫骨侧止点面积重建百分比为16.2%至123.1%,股骨侧为25.5%至176.7%,各移植物类型间差异显著(P < .05)。
  • 平均而言,PT可填充胫骨止点面积的32.8%,HS为53.6%,QT为69.5%。
  • 基于既往尸体研究提示移植物大小目标应为胫骨止点面积的50.2%±15%,HS组82.7%的患者在此范围内(QT组36.9%,PT组30.5%),而PT组65.2%低于该范围、QT组60.9%高于该范围。

关键数值与推荐

  • 移植物大小目标参考既往尸体研究:胫骨止点面积的50.2%±15%。
  • HS组82.7%在目标范围内,PT组65.2%低于目标范围,QT组60.9%高于目标范围。

临床怎么用

  • 作者认为这些结果可能有助于外科医生进行术前规划,磁共振成像测量可帮助确定个体化移植物选择以充分恢复原生ACL。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent literature correlated anterior cruciate ligament (ACL) reconstruction failure to smaller diameter of the harvested hamstring (HS) autograft. However, this approach may be a simplification, as relation of graft size to native ACL size is not typically assessed and oversized grafts may impart their own complications. PURPOSE: To evaluate in vivo data to determine if the commonly used autografts reliably restore native ACL size. STUDY DESIGN: Descriptive laboratory study. METHODS: Intraoperative data of the tibial insertion area and HS graft diameter were collected and retrospectively evaluated for 46 patients who underwent ACL reconstruction with HS autografts. Magnetic resonance imaging measurements of the cross-sectional area (CSA) of the possible patellar tendon (PT) and quadriceps tendon (QT) autografts were also done for each patient. The percentages of tibial insertion site area restored by the 3 possible grafts were then calculated and compared for each individual. RESULTS: The mean ACL tibial insertion area was 107.2 mm2 (60.5-155.5 mm2). The mean CSAs of PT, HS, and QT were 33.2, 55.3, and 71.4 mm2, respectively. When all grafts were evaluated, the percentage reconstruction of the insertion area varied from 16.2% to 123.1% on the tibial site and from 25.5% to 176.7% on the femoral site, differing significantly for each graft type ( P < .05). On average, 32.8% of the tibial insertion area would have been filled with PT, 53.6% by HS, and 69.5% by QT. Based on previous cadaveric studies indicating that graft size goal should be 50.2% ± 15% of the tibial insertion area, 82.7% of patients in the HS group were within this range (36.9%, QT; 30.5%, PT), while 65.2% in the PT group were below it and 60.9% in the QT group were above it. CONCLUSION: ACL insertion size and the CSAs of 3 commonly used grafts vary greatly for each patient and are not correlated with one another. Thus, if the reconstructed ACL size is determined by the harvested autograft size alone, native ACL size may not be adequately restored. PT grafts tended to undersize the native ACL, while QT might oversize it. CLINICAL RELEVANCE: These results may help surgeons in preoperative planning, as magnetic resonance imaging measurements can be helpful in determining individualized graft choice to adequately restore the native ACL.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Offerhaus C, Albers M, Nagai K, et al. Individualized Anterior Cruciate Ligament Graft Matching: In Vivo Comparison of Cross-sectional Areas of Hamstring, Patellar, and Quadriceps Tendon Grafts and ACL Insertion Area. Am J Sports Med. 2018. PMID: 30059247. doi:10.1177/0363546518786032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。